DLH to Deliver Leading-Edge Enterprise and Specialized Information Technology Services to the National Cancer Institute
February 28 2023 - 8:00AM
DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the
“Company”), a leading provider of science research and
development, systems engineering and integration, and digital
transformation solutions to federal agencies, today announced that
its subsidiary Grove Resource Solutions LLC (“GRSi”) has been
awarded a multiple-award blanket purchase agreement (“BPA”) to
provide leading-edge enterprise and specialized information
technology (“IT”) services to the National Cancer Institute’s
(“NCI”) Center for Biomedical Informatics and Information
Technology (“CBIIT”). NCI is an institute of the National
Institutes of Health (“NIH”) dedicated to leading, conducting, and
supporting cancer research across the nation with the aim of
advancing scientific knowledge and prolonging human lives; CBIIT
provides critical IT services in support of that mission.
The multiple-award contract has a five-year period of
performance, and the government estimates that the aggregate
ceiling for this BPA will total $1.7 billion. Specific values will
be allocated to contractors as call orders are competed and
awarded. Including DLH, eight awardees have been named to this
contract. GRSi has supported CBIIT through the organization’s
enterprise Desktop Management and User Support program since
2018.
“We are thrilled to expand our partnership with CBIIT under this
contract vehicle and strive to continue delivering the
best-in-class services and solutions the NCI research community has
come to expect of GRSi,” said Diane Yarnell, President of GRSi’s
Health IT Business Unit.
This BPA, managed by CBIIT, provides a streamlined mechanism for
the entire NCI community to access comprehensive and innovative IT
services. Through GRSi, DLH will act as a prime vendor on this
contract and provide NCI with the specialized professional IT
support required to accomplish their complex, mission-critical
goals. Under call orders to be awarded under the BPA
responsibilities may include operations and maintenance,
information systems security, service desk, engineering, cloud
platform management and support, enterprise Software as a Service
(“SaaS”) platform management, data management, and more.
“We are proud to build upon our existing relationship with NCI
as the institute works tirelessly to improve research, training,
and information dissemination with respect to the causes and
treatment of cancer,” said Zach Parker, DLH President & CEO.
“We will utilize our high-end IT and technical capabilities and our
industry-leading workforce to support this vital public health
mission through digital transformation.”
About DLH
DLH (NASDAQ:DLHC) delivers improved health and national security
readiness solutions for federal programs through science research
and development, systems engineering and integration, and digital
transformation. The Company’s experts in public health, performance
evaluation, and health operations solve the complex problems faced
by civilian and military customers alike, leveraging digital
transformation, artificial intelligence, advanced analytics,
cloud-based applications, telehealth systems, and more. With over
3,200 employees dedicated to the idea that “Your Mission is Our
Passion,” DLH brings a unique combination of government sector
experience, proven methodology, and unwavering commitment to
innovation to improve the lives of millions. For more information,
visit www.DLHcorp.com.
Safe Harbor Statement under the Private Securities
Litigation Reform Act of 1995:
This press release may contain forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. These statements relate to future events or DLH`s future
financial performance. Any statements that refer to expectations,
projections or other characterizations of future events or
circumstances or that are not statements of historical fact
(including without limitation statements to the effect that the
Company or its management “believes”, “expects”, “anticipates”,
“plans”, “intends” and similar expressions) should be considered
forward looking statements that involve risks and uncertainties
which could cause actual events or DLH’s actual results to differ
materially from those indicated by the forward-looking statements.
Forward-looking statements in this release include, among others,
statements regarding estimates of future revenues. These statements
reflect our belief and assumptions as to future events that may not
prove to be accurate. Our actual results may differ materially from
such forward-looking statements made in this release due to a
variety of factors, including: the outbreak of the novel
coronavirus (“COVID-19”), including the measures to reduce its
spread, and its impact on the economy and demand for our services,
are uncertain, cannot be predicted, and may precipitate or
exacerbate other risks and uncertainties; the risk that we will not
realize the anticipated benefits of the GRSi acquisition;
(including anticipated future financial operating performance and
results); diversion of management’s attention from normal daily
operations of the business and the challenges of managing larger
and more widespread operations resulting from the acquisition; the
inability to retain GRSi employees and customers; contract awards
in connection with re-competes for present business and/or
competition for new business; the risks and uncertainties
associated with client interest in and purchases of new services;
compliance with new bank financial and other covenants; changes in
client budgetary priorities; government contract procurement (such
as bid and award protests, small business set asides, loss of work
due to organizational conflicts of interest, etc.) and termination
risks; the ability to successfully integrate the operations of GRSi
and any future acquisitions; the impact of inflation and higher
interest rates; and other risks described in our SEC filings. For a
discussion of such risks and uncertainties which could cause actual
results to differ from those contained in the forward-looking
statements, see “Risk Factors” in the Company’s periodic reports
filed with the SEC, including our Annual Report on Form 10-K for
the fiscal year ended September 30, 2022, as well as subsequent
reports filed thereafter. The forward-looking statements contained
herein are not historical facts, but rather are based on current
expectations, estimates, assumptions and projections about our
industry and business.
Such forward-looking statements are made as of the date hereof
and may become outdated over time. The Company does not assume any
responsibility for updating forward-looking statements, except as
may be required by law.
CONTACTS:
MEDIA
Email: dlh.communications@dlhcorp.com
INVESTOR RELATIONS
Contact: Chris WittyPhone: 646-438-9385Email:
cwitty@darrowir.com
DLH (NASDAQ:DLHC)
Historical Stock Chart
From Jun 2024 to Jul 2024
DLH (NASDAQ:DLHC)
Historical Stock Chart
From Jul 2023 to Jul 2024